Eloxx Pharmaceuticals, Inc. (ELOX) › Shareholders' EquityEloxx Pharmaceuticals, Inc. (ELOX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.1998: $01999: $912.2K2000: $1.52M2001: -$206.7K2002: $4.79M2003: $2.86M2004: $4.73M2005: $5.59M2006: $2.95M2007: $2.69M2008: $9.84M2009: $5.67M2010: $7.98M2011: $4.52M2012: $3.45M2013: $3.79M2014: $2.77M2015: $643.0K2016: $610.0K2017: $21.36M2018: $42.91M2019: $36.21M2020: $10.23M2021: $22.38M2022: -$10.66M2023: -$22.60M2024: -$24.34M2025: -$11.91M-$11.91M1998Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$11.91M+51.1%2024-$24.34M-7.7%2023-$22.60M-112.0%2022-$10.66M-147.6%2021$22.38M+118.8%2020$10.23M-71.8%2019$36.21M-15.6%2018$42.91M+100.9%2017$21.36M+3401.8%2016$610.0K-5.1%2015$643.0K-76.8%2014$2.77M-26.7%2013$3.79M+9.6%2012$3.45M-23.6%2011$4.52M-43.4%2010$7.98M+40.8%2009$5.67M-42.4%2008$9.84M+265.7%2007$2.69M-8.9%2006$2.95M-47.2%2005$5.59M+18.2%2004$4.73M+65.6%2003$2.86M-40.3%2002$4.79M+2415.1%2001-$206.7K-113.6%2000$1.52M+66.5%1999$912.2K—1998$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share